MYOD1 and myotonic dystrophy type 1: Gemcitabine was identified as a DMPK RNA foci inhibitor in a previous screen of DM1 fibroblasts with the effect validated in immortalized and MyoD-converted to myoblasts, but was not further investigated given evidence of cytotoxicity [53].